Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Selling, General & Administrative Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Selling, General & Administrative
-$323.5m
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
-17%
Johnson & Johnson
NYSE:JNJ
Selling, General & Administrative
-$22.2B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
Selling, General & Administrative
-$8B
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-5%
Pfizer Inc
NYSE:PFE
Selling, General & Administrative
-$14.8B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Selling, General & Administrative
-$10.7B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Selling, General & Administrative
-$8.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-2%

See Also

What is Supernus Pharmaceuticals Inc's Selling, General & Administrative?
Selling, General & Administrative
-323.5m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Selling, General & Administrative amounts to -323.5m USD.

What is Supernus Pharmaceuticals Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-17%

Over the last year, the Selling, General & Administrative growth was 2%. The average annual Selling, General & Administrative growth rates for Supernus Pharmaceuticals Inc have been -8% over the past three years , -14% over the past five years , and -17% over the past ten years .

Back to Top